Studies have shown that IRS2 may inhibit hyperglycemia and hyperinsulinemia, while promoting endogenous glucose production and glycogen synthesis (Previs et al., 2000; Bertinat et al., 2018). This evidence concerns the gene IRS2 and hyperinsulinism.